Patients with chronic pain and abnormal pituitary function require investigation

Lancet

Volumn 361, Issue 9376, 2003, Pages 2203-2204

  Merza, Z ^a   Edwards, N ^a   Walters, S J ^b   Newell Price, J ^a   Ross, Richard J M ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; OPIATE;

ADULT; ARTICLE; CHRONIC PAIN; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOCRINE FUNCTION TEST; FATIGUE; FEMALE; HUMAN; HYPOPHYSIS DISEASE; HYPOPHYSIS FUNCTION; MALE; OBESITY; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 0038167722     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)13775-0     Document Type: Article

References (5)

1. Cushman P. Jr. Growth hormone in narcotic addiction. J Clin Endocrinol Metab. 35:1972;352-358.
2. Bolelli G., Lafisca S., Flamigni C., et al. Heroin addiction: relationship between the plasma levels of testosterone, dihydrotestosterone, androstenedione, LH, FSH, and the plasma concentration of heroin. Toxicology. 15:1979;19-29.
3. Celani M.F., Carani C., Montanini V., et al. Further studies on the effects of heroin addiction on the hypothalamic-pituitary-gonadal function in man. Pharmacol Res Commun. 16:1984;1193-1203.
4. Cleare A.J., Heap E., Malhi G.S., Wessely S., O'Keane V., Miell J. Low-dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial. Lancet. 353:1999;455-458.
5. Abs R., Verhelst J., Maeyaert J., et al. Endocrine consequences of long-term intrathecal administration of opioids. J Clin Endocrinol Metab. 85:2000;2215-2222.